Management of High Blood Pressure in Children and Adolescents

Cardiology Clinics

Volumn 28, Issue 4, 2010, Pages 597-607

  Kavey, Rae Ellen W ^a   Daniels, Stephen R ^b,c   Flynn, Joseph T ^d  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Children's Hospital Colorado   (United States)

^c CHILDREN S HOSPITAL COLORADO   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Adolescents; Children; High blood pressure; Hypertension; Management

Indexed keywords

ALISKIREN; AMILORIDE; AMLODIPINE; BENAZEPRIL; CANDESARTAN; CAPTOPRIL; CHLOROTHIAZIDE; DIAZOXIDE; ENALAPRIL; EPLERENONE; FENOLDOPAM; FOSINOPRIL; FUROSEMIDE; HYDRALAZINE; IRBESARTAN; LABETALOL; LISINOPRIL; LOSARTAN; METHYLDOPA; METOPROLOL; MINOXIDIL; NITROPRUSSIDE SODIUM; OLMESARTAN; PROPRANOLOL; QUINAPRIL; RAMIPRIL; SPIRONOLACTONE; TELMISARTAN; UNINDEXED DRUG; VALSARTAN;

ADOLESCENT; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; EXERCISE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; OBESITY; PATHOGENESIS; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ADOLESCENT; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; OBESITY; REFERENCE VALUES; RISK FACTORS; WEIGHT LOSS;

EID: 77957727853     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2010.07.004     Document Type: Review

References (60)

1. Din-Dzietham R., Liu Y., Bielo M.V., et al. High blood pressure trends in children and adolescents in National Surveys, 1963 to 2003. Circulation 2007, 116:1488-1496.
2. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114(Suppl):555-576.
3. Muntner P., He J., Cutler J.A., et al. Trends in blood pressure among children and adolescents. JAMA 2004, 291:2107-2113.
4. McNiece K.L., Poffenbarger T.S., Turner J.L., et al. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 2007, 150:640-644.
5. Sorof J., Daniels S.R. Obesity hypertension inn children: a problem of epidemic proportions. Hypertension 2002, 40:441-447.
6. Urbina E., Alpert B., Flynn J., et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment. Hypertension 2008, 552:433-451.
7. Lande M.B., Carson N.L., Roy J., et al. Effects of childhood primary hypertension on carotid intima media thickness. A matched controlled study. Hypertension 2006, 48:40-44.
8. Lim S.M., Kim H.C., Lee H.S., et al. Association between blood pressure and carotid intima-media thickness. J Pediatr 2009, 154:667-671.
9. Daniels S.R., Loggie J., Khoury P., et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998, 97:1907-1911.
10. Chen X., Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-analysis. Circulation 2008, 117:3171-3180.
11. Raitakari O.T., Juonola M., Kahonen M., et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003, 290:2277-2283.
12. Li S., Chen W., Srinivasan S.R., et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 2003, 290:2271-2276.
13. Gidding S.S., Barton B.A., Dorgan J.A. Higher self-reported activity is associated with lower systolic blood pressure: the Dietary Intervention Study in Childhood (DISC). Pediatrics 2006, 118:2388-2393.
14. Niinikoski H., Jula A., Viikari J., et al. Blood pressure is lower in children and adolescents with low-saturated-fat diet since infancy: the Special Turku Coronary Risk Factor Intervention Project. Hypertension 2009, 53:918-924.
15. Hansen M.L., Gunn P.W., Kaelber D.C. Underdiagnosis of hypertension in children and adolescents. JAMA 2007, 298(8):874-879.
16. Kaelber D.C., Pickett F. Simple table to identify children and adolescents needing further evaluation of blood pressure. Pediatrics 2009, 123:e972-e974.
17. Rosner B., Prineas R., Daniels S.R., et al. Blood pressure differences between blacks and whites in relation to body size among US children and adolescents. Am J Epidemiol 2000, 151:1007-1019.
18. Reinehr T., Andler W., Denzer C., et al. Cardiovascular risk factors in overweight children and adolescents: relation to gender, age and degree of overweight. Nutr Metab Cardiovasc Dis 2005, 15:181-187.
19. Sorof J.M., Lai D., Turner J., et al. Overweight, ethnicity and prevalence of hypertension in school-aged children. Pediatrics 2004, 113:475-482.
20. Grebla R.C., Rodriguez C.J., Borrell L.N., et al. Prevalence and determinants of isolated systolic hypertension among young adults: the 1999-2004 US National Health and Nutrition Examination Survey. J Hypertens 2010, 28:15-23.
21. Shear C.L., Freedman D.S., Burke G.L., et al. Body fat patterning and blood pressure in children and young adults: the Bogalusa Heart Study. Hypertension 1987, 9:236-244.
22. Rocchinin A.P., Katch V., Kveselis D., et al. Insulin and renal sodium retention in obese adolescents. Hypertension 1989, 14:367-374.
23. Rocchini A.P., Key J., Bondie D., et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989, 321:580-585.
24. Rocchini A.P., Moorehead C., DeRemer S., et al. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 1990, 15:861-866.
25. Jiang X., Srinivasan S.R., Urbina E., et al. Hyperdynamic circulation and cardiovascular risk in children and adolescents: the Bogalusa Heart Study. Circulation 1995, 91:1101-1106.
26. Sorof J.M., Poffenbarger T., Franco K., et al. Isolated systolic hypertension, obesity and hyperkinetic hemodynamic states in children. J Pediatr 2002, 140:660-666.
27. Feig D.I., Kang D.-H., Johnson R.J. Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821.
28. Feig D.I., Johnson R.J. Hyperuricemia in childhood primary hypertension. Hypertension 2003, 42:247-252.
29. Feig D.I., Soletsky B., Johnson R.J. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008, 300:924-932.
30. Stabouli S., Kotsis V., Papamichael C., et al. Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. J Pediatr 2005, 147:651-656.
31. Rocchini A.P., Moorehead C., Katch V., et al. Forearm resistance vessel abnormalities and insulin resistance in obese adolescents. Hypertension 1992, 19:615-620.
32. Tuck M.I., Sowers J., Dornfield L., et al. The effect of weight reduction on blood pressure plasma renin activity and plasma aldosterone level in obese patients. N Engl J Med 1981, 304:930-933.
33. Rocchini A.P., Katch V.L., Grekin R., et al. Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol 1986, 57:613-618.
34. Sjostrom C.D., Lissner L., Wedel H., et al. Differential long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000, 36:20-25.
35. Rocchini A.P., Katch V., Anderson J., et al. Blood pressure in obese adolescents: effect of weight loss. Pediatrics 1988, 82:116-123.
36. Kavey R.E.W., Kveselis D.A., Atallah N., et al. White coat hypertension in childhood: evidence for end-organ effect. J Pediatr 2007, 150:491-497.
37. He F.J., Graham A.M. Importance of salt in determining blood pressure in children. Meta-analysis of controlled trials. Hypertension 2006, 48:861-869.
38. Appel L.J., Moore T.J., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997, 336(16):1117-1124.
39. Folsom A.R., Parker E.D., Harnack L.J. Degree of concordance with DASH diet guidelines and incidence of hypertension and fatal cardiovascular disease. Am J Hypertens 2007, 20(3):225-232.
40. Couch S.C., Saelens B.E., Levin L., et al. The efficacy of a clinic-based behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure. J Pediatr 2008, 152(4):494-501.
41. Kay J.P., Alemzadeh R., Langley G., et al. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 2001, 50(12):1457-1461.
42. Srinivasan S., Ambler G.R., Baur L.A., et al. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. J Clin Endocrinol Metab 2006, 91(6):2074-2080.
43. Freemark M., Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001, 107(4):E55.
44. Maahs D., de Serna D.G., Kolotkin R.L., et al. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocr Pract 2006, 12(1):18-28.
45. Chanoine J.P., Hampl S., Jensen C., et al. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005, 293(23):2873-2883.
46. Ozkan B., Bereket A., Turan S., et al. Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur J Pediatr 2004, 163(12):738-741.
47. Berkowitz R.I., Wadden T.A., Tershakovec A.M., et al. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA 2003, 289(14):1805-1812.
48. García-Morales L.M., Berber A., Macias-Lara C.C., et al. Use of sibutramine in obese Mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial. Clin Ther 2006, 28(5):770-782.
49. Daniels S.R., Long B., Crow S., et al. Sibutramine Adolescent Study Group. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study. Pediatrics 2007, 120(1):e147-e157.
50. Tsai W.S., Inge T.H., Burd R.S. Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med 2007, 161(3):217-221.
51. Ippisch H.M., Inge T.H., Daniels S.R., et al. Reversibility of cardiac abnormalities in morbidly obese adolescents. J Am Coll Cardiol 2008, 51:1342-1348.
52. Flynn J.T. Pediatric use of antihypertensive medications: much more to learn. Curr Ther Res Clin Exp 2001, 62:314-328.
53. Roberts R., Rodriguez W., Murphy D., et al. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA 2003, 290:905-911.
54. Dunne J. The European Regulation on medicines for paediatric use. Paediatr Respir Rev 2007, 8:177-183.
55. Ghulam A., Keen K., Tuleu C., et al. Poor preservation efficacy versus quality and safety of pediatric extemporaneous liquids. Ann Pharmacother 2007, 41:857-860.
56. Flynn J.T., Meyers K.C., Neto J.P., et al. Pediatric Valsartan Study Group. Efficacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged one to five years. Hypertension 2008, 52:222-228.
57. Wühl E., Trivelli A., Picca S., et al. for the ESCAPE Trial Group. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009, 361:1639-1650.
58. Assadi F. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol 2007, 28:27-33.
59. Flynn J.T., Daniels S.R. Pharmacologic treatment of hypertension in children and adolescents. J Pediatr 2006, 149:746-754.
60. Benjamin D.K., Smith P.B., Jadhav P., et al. Pediatric antihypertensive trial failures: analysis of end points and dose range. Hypertension 2008, 51:834-840.